<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="EN" article-type="case-report">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Tumor Res Treat</journal-id>
<journal-id journal-id-type="publisher-id">BTRT</journal-id>
<journal-title-group>
<journal-title>Brain Tumor Research and Treatment</journal-title>
</journal-title-group>
<issn pub-type="ppub">2288-2405</issn>
<issn pub-type="epub">2288-2413</issn>
<publisher>
<publisher-name>The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.14791/btrt.2016.4.1.17</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cellular Neurothekeoma of the Scalp in the Elderly</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Min-Cheol</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seung</surname>
<given-names>Won-Bae</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

</contrib-group>

<aff id="A1">Department of Neurosurgery, Gospel Hospital, Kosin University College of Medicine, Busan, Korea.</aff>

<author-notes>
<corresp>Correspondence: Won-Bae Seung. Department of Neurosurgery, Gospel Hospital, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 49267, Korea. Tel: +82-51-990-6465, Fax: +82-51-990-3042, <email>peiothmd@daum.net</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>04</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>04</month>
<year>2016</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>20</lpage>

<history>
<date date-type="received">
<day>02</day>
<month>06</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>08</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>12</month>
<year>2015</year>
</date>
</history>

<permissions>
<copyright-statement>Copyright &#x00A9; 2016 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<p>Cellular neurothekeoma (CNT) is an uncommon variant of neurothekeoma that is composed of pithelioid to spindled cells with variable nuclear atypia or pleomorphism but no myxoid stroma. CNT occurs predominantly in the head and neck or upper trunk of children and young adults, with female predominance. The following case is different from typical CNTs. An 88-year-old female presented with a palpable mass on the scalp, which we excised. Histologically, the tumor was non-encapsulated and composed of spindled and epithelioid cells arranged in fascicles and nodules separated by a collagen-rich stroma. Immunohistochemical analysis showed that the epithelioid and spindle-shaped cells were focally positive for vimentin, neuron-specific enolase, smooth muscle actin, CD68, and CD10 but negative for S-100 protein, HMB-45, epithelial membrane antigen, and CD34. We report a new case of CNT that arose in the scalp of an older patient and that was associated with uncommon clinical, histological, and immunohistochemical profiles.</p>
</abstract>

<kwd-group>
<kwd>Nerve sheath myxoma</kwd>
<kwd>Neurothekeoma</kwd>
<kwd>Scalp</kwd>
</kwd-group>

</article-meta>
</front>

<body>

<sec sec-type="intro">
<title>INTRODUCTION</title>
  <p>Neurothekeoma (NT) is a benign skin tumor that is usually related to a myxoid neoplasm of the soft tissue with presumed neural differentiation [<xref ref-type="bibr" rid="B1">1</xref><xref ref-type="bibr" rid="B2">2</xref><xref ref-type="bibr" rid="B3">3</xref>]. NTs usually occur in the first or second decade of life and have a female dominance [<xref ref-type="bibr" rid="B1">1</xref>]. Approximately 30% of these lesions involve the head and neck; however, they may less frequently involve extracutaneous sites, such as breast, oral cavity, spinal intradural space, and hypopharynx [<xref ref-type="bibr" rid="B1">1</xref><xref ref-type="bibr" rid="B4">4</xref><xref ref-type="bibr" rid="B5">5</xref><xref ref-type="bibr" rid="B6">6</xref><xref ref-type="bibr" rid="B7">7</xref><xref ref-type="bibr" rid="B8">8</xref>]. There are two histopathologic variants: classic (myxoid) and cellular, although cellular neurothekeoma (CNT) was recently determined to be histogenetically unrelated to classic NT [<xref ref-type="bibr" rid="B2">2</xref><xref ref-type="bibr" rid="B9">9</xref>].</p>

  <p>We report a new case of CNT that arose in the scalp of an older patient and that was associated with uncommon clinical, histological, and immunohistochemical profiles.</p>
</sec>

<sec sec-type="cases">
<title>CASE REPORT</title>
  <p>An 88-year-old woman presented to our hospital with a painless, palpable mass in the left parietal area of the scalp that had shown a slow increase in size to 6 cm in diameter over two years. Radiologic evaluations with computed tomography and magnetic resonance imaging demonstrated a well-defined, heterogeneous, enhancing mass in the left parietal convexity with focal cortical defect of the left parietal bone (<xref ref-type="fig" rid="F1">Fig. 1A</xref>).</p>

  <p>Surgical excision of the lesion was performed under general anesthesia. A hard, whitish-grey mass with little bleeding was completely removed (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). The scattered calcified lesions of the tumor bed were drilled out.</p>

  <p>Histopathologically, the tumor was non-encapsulated and composed of epithelioid and spindle-shaped cells separated by prominent fibrous septa were observed in fascicles or nodules with a geographical pattern (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Also, this tumor was composed of nests and bundles of epithelioid to spindle cells with sparse myxoid matrix (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). The tumor cells had oval or round vesicular nuclei and abundant pale eosinophilic cytoplasm with ill-defined cell borders.</p>

  <p>Some cells had nuclear pleomorphism with prominent nuclei, mild to moderate cellular pleomorphism including giant cells is seen (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). Mitotic activity is low (3/10 high power field) (<xref ref-type="fig" rid="F2">Fig. 2D</xref>). Distinct perineural invasion and tumor necrosis are not presented. The tumor involved the margins of the excision and infiltrated into fat and skeletal muscle. Immunohistochemical analysis showed that the epithelioid and spindle-shaped cells were at least focally positive for vimentin, neuron-specific enolase (NSE) (<xref ref-type="fig" rid="F3">Fig. 3A</xref>), smooth muscle actin (SMA) (<xref ref-type="fig" rid="F3">Fig. 3B</xref>), CD68 (<xref ref-type="fig" rid="F3">Fig. 3C</xref>), and CD10 (<xref ref-type="fig" rid="F3">Fig. 3D</xref>) but negative for S-100 protein, HMB-45, epithelial membrane antigen (EMA), and CD34. On the basis of these findings, a diagnosis of CNT was made.</p>
</sec>

<sec sec-type="discussion">
<title>DISCUSSION</title>
  <p>NT is an unusual benign cutaneous tumor involving the dermis and is composed of distinct lobules of bland spindle cells separated by fibrous connective tissue [<xref ref-type="bibr" rid="B10">10</xref><xref ref-type="bibr" rid="B11">11</xref>]. CNT is an uncommon variant of NT that is hypercellular and lacks myxoid stroma [<xref ref-type="bibr" rid="B2">2</xref>]. Typically, CNTs occur as a solitary, asymptomatic papule during the first three decades of life, demonstrating a female predominance. The tumors most often arise on the upper extremities and head and neck [<xref ref-type="bibr" rid="B9">9</xref><xref ref-type="bibr" rid="B12">12</xref><xref ref-type="bibr" rid="B13">13</xref>]. The mean tumor size is 1 cm, and 90% are smaller than 2 cm [<xref ref-type="bibr" rid="B9">9</xref>]. CNTs are generally poorly marginated, micronodular, or lobulated neoplasms composed of epithelioid to spindled cells with abundant pale eosinophilic cytoplasm. NTs and CNTs are similarly immunoreactive for vimentin, NKI/C3, CD10, SMA, and CD68 and are negative for HMB-45, cytokeratin, desmin, Melan A, and S-100 protein [<xref ref-type="bibr" rid="B2">2</xref><xref ref-type="bibr" rid="B10">10</xref>]. In our case, such a tumor was found on the scalp of an elderly woman and was very large at 6 cm in size. These characteristics were different from any other previously reported CNTs.</p>

  <p>CNTs might be mistaken for malignant tumors, such as sarcomas, because of their hypercellularity, the presence of nuclear atypia, and the extension into fat or skeletal muscle [<xref ref-type="bibr" rid="B2">2</xref>]. The chief differential diagnostic considerations for CNTs are dermal nerve sheath myxoma (DNSM), also called myxoid NT. DNSM is a lobulated tumor composed of variably epithelioid to spindled or stellate cells in an abundant myxoid matrix, whereas CNTs can show focally myxoid stroma or rare extensive myxoid change [<xref ref-type="bibr" rid="B9">9</xref>]. While CNTs show irregular, infiltrative margins within surrounding dermal collagen or subcutaneous adipose tissue, the lobules of DNSM are very sharply demarcated. In pathologic aspect, other common differential diagnoses for CNTs include classic (myxoid) NT, fibrohistiocytic tumors, melanocytic tumors, cellular perineuroma. Unlike this case, myxoid NT shows prominent myxoid stroma (&#x003E;50% myxoid matrix) and expression of S-100 [<xref ref-type="bibr" rid="B9">9</xref><xref ref-type="bibr" rid="B12">12</xref><xref ref-type="bibr" rid="B13">13</xref><xref ref-type="bibr" rid="B14">14</xref>]. The most helpful pathologic finding in support of CNTs, comparing with fibrohistiocytic tumors, is nested patterns of epitheliod and more plump spindle tumor cells with vesicular or open-chromated nuclei and indistinct cell borders. In addition, the positive reactions for NSE and CD10 and lack of expression of CD34 are helpful to differential diagnosis. Melanocytic tumors show almost always positive reaction for HMB-45 and S-100, in contrast to this case. Cellular perienuroma expresses diffusely or focally EMA differentiated from this case. Based on the report of Fetsch et al. [<xref ref-type="bibr" rid="B10">10</xref>] showing a high recurrence rate of DNSM, this differential diagnosis is clinically important because CNTs rarely recur. The strong positive staining for neuroendocrine markers such as NSE, chromogranin, synaptophysin, and CD56 suggest possible neuroendocrine differentiation of the tumor cells [<xref ref-type="bibr" rid="B2">2</xref>]; however, Hornick and Fletcher [<xref ref-type="bibr" rid="B9">9</xref>] suggested that all tumors are diffusely positive for NKI/C3, and most (around 90%) are positive for NSE because these markers lack specificity. In our case, the tumor likely did not represent neuroendocrine differentiation because of its focally positive NSE.</p>

  <p>CNTs are benign tumors with nuclear atypia and only occasionally recur locally when the tumor has been marginally excised or has involved excision margins. Incomplete excision of CNT can lead to recurrence; therefore, total excision is recommended. Large tumor size (&#x003E;2 cm) and atypical histologic features including high mitotic rate, pleomorphism, and infiltration of fat seem to have no clinical significance [<xref ref-type="bibr" rid="B9">9</xref>].</p>

  <p>In conclusion, CNTs are benign lesions that do not recur following total excision. Definitive diagnosis of CNT can be made with immunohistochemical analysis. Complete excision of the tumor with negative margins is curative.</p>
</sec>

</body>

<back>

<fn-group>
<fn fn-type="conflict">
<label>Conflicts of Interest</label>
  <p>The authors have no financial conflicts of interest.</p>
</fn>
</fn-group>

<ref-list>

  <ref id="B1">
    <label>1</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Cohen</surname>
          <given-names>NA</given-names>
        </name>
        <name>
          <surname>Samadi</surname>
          <given-names>DS</given-names>
        </name>
        <name>
          <surname>Pawel</surname>
          <given-names>BR</given-names>
        </name>
        <name>
          <surname>Kazahaya</surname>
          <given-names>K</given-names>
        </name>
      </person-group>
      <article-title>Cellular neurothekeoma of the maxilla</article-title>
      <source>Ann Otol Rhinol Laryngol</source>
      <year>2004</year>
      <volume>113</volume>
      <fpage>384</fpage>
      <lpage>387</lpage>
    </element-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>D'Antonio</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Cuomo</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Angrisani</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Addesso</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Angrisani</surname>
          <given-names>P</given-names>
        </name>
      </person-group>
      <article-title>Cellular neurothekeoma with neuroendocrine differentiation</article-title>
      <source>Dermatol Online J</source>
      <year>2011</year>
      <volume>17</volume>
      <fpage>2</fpage>
    </element-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Pulitzer</surname>
          <given-names>DR</given-names>
        </name>
        <name>
          <surname>Reed</surname>
          <given-names>RJ</given-names>
        </name>
      </person-group>
      <article-title>Nerve-sheath myxoma (perineurial myxoma)</article-title>
      <source>Am J Dermatopathol</source>
      <year>1985</year>
      <volume>7</volume>
      <fpage>409</fpage>
      <lpage>421</lpage>
    </element-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Chow</surname>
          <given-names>LT</given-names>
        </name>
        <name>
          <surname>Ma</surname>
          <given-names>TK</given-names>
        </name>
        <name>
          <surname>Chow</surname>
          <given-names>WH</given-names>
        </name>
      </person-group>
      <article-title>Cellular neurothekeoma of the hypopharynx</article-title>
      <source>Histopathology</source>
      <year>1997</year>
      <volume>30</volume>
      <fpage>192</fpage>
      <lpage>194</lpage>
    </element-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Katsourakis</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Kapranos</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Papanicolaou</surname>
          <given-names>SI</given-names>
        </name>
        <name>
          <surname>Patrikiou</surname>
          <given-names>A</given-names>
        </name>
      </person-group>
      <article-title>Nerve-sheath myxoma (neurothekeoma) of the oral cavity: a case report and review of the literature</article-title>
      <source>J Oral Maxillofac Surg</source>
      <year>1996</year>
      <volume>54</volume>
      <fpage>904</fpage>
      <lpage>906</lpage>
    </element-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Paulus</surname>
          <given-names>W</given-names>
        </name>
        <name>
          <surname>Jellinger</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Perneczky</surname>
          <given-names>G</given-names>
        </name>
      </person-group>
      <article-title>Intraspinal neurothekeoma (nerve sheath myxoma). A report of two cases</article-title>
      <source>Am J Clin Pathol</source>
      <year>1991</year>
      <volume>95</volume>
      <fpage>511</fpage>
      <lpage>516</lpage>
    </element-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Vij</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Jaiswal</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Agrawal</surname>
          <given-names>V</given-names>
        </name>
        <name>
          <surname>Jaiswal</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Behari</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>Nerve sheath myxoma (neurothekeoma) of cerebellopontine angle: case report of a rare tumor with brief review of literature</article-title>
      <source>Turk Neurosurg</source>
      <year>2013</year>
      <volume>23</volume>
      <fpage>113</fpage>
      <lpage>116</lpage>
    </element-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Wee</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Tan</surname>
          <given-names>CE</given-names>
        </name>
        <name>
          <surname>Raju</surname>
          <given-names>GC</given-names>
        </name>
      </person-group>
      <article-title>Nerve sheath myxoma of the breast. A light and electron microscopic, histochemical and immunohistochemical study</article-title>
      <source>Virchows Arch A Pathol Anat Histopathol</source>
      <year>1989</year>
      <volume>416</volume>
      <fpage>163</fpage>
      <lpage>167</lpage>
    </element-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hornick</surname>
          <given-names>JL</given-names>
        </name>
        <name>
          <surname>Fletcher</surname>
          <given-names>CD</given-names>
        </name>
      </person-group>
      <article-title>Cellular neurothekeoma: detailed characterization in a series of 133 cases</article-title>
      <source>Am J Surg Pathol</source>
      <year>2007</year>
      <volume>31</volume>
      <fpage>329</fpage>
      <lpage>340</lpage>
    </element-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Fetsch</surname>
          <given-names>JF</given-names>
        </name>
        <name>
          <surname>Laskin</surname>
          <given-names>WB</given-names>
        </name>
        <name>
          <surname>Hallman</surname>
          <given-names>JR</given-names>
        </name>
        <name>
          <surname>Lupton</surname>
          <given-names>GP</given-names>
        </name>
        <name>
          <surname>Miettinen</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information</article-title>
      <source>Am J Surg Pathol</source>
      <year>2007</year>
      <volume>31</volume>
      <fpage>1103</fpage>
      <lpage>1114</lpage>
    </element-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Gallager</surname>
          <given-names>RL</given-names>
        </name>
        <name>
          <surname>Helwig</surname>
          <given-names>EB</given-names>
        </name>
      </person-group>
      <article-title>Neurothekeoma--a benign cutaneous tumor of neural origin</article-title>
      <source>Am J Clin Pathol</source>
      <year>1980</year>
      <volume>74</volume>
      <fpage>759</fpage>
      <lpage>764</lpage>
    </element-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Lane</surname>
          <given-names>JE</given-names>
        </name>
        <name>
          <surname>Mullins</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Davis</surname>
          <given-names>LS</given-names>
        </name>
      </person-group>
      <article-title>Clinical pathologic challenge. Cellular neurothekeoma</article-title>
      <source>Am J Dermatopathol</source>
      <year>2006</year>
      <volume>28</volume>
      <fpage>65</fpage>
      <lpage>66</lpage>
      <comment>answer and discussion 87-8</comment>
    </element-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Zedek</surname>
          <given-names>DC</given-names>
        </name>
        <name>
          <surname>White</surname>
          <given-names>WL</given-names>
        </name>
        <name>
          <surname>McCalmont</surname>
          <given-names>TH</given-names>
        </name>
      </person-group>
      <article-title>Desmoplastic cellular neurothekeoma: clinicopathological analysis of twelve cases</article-title>
      <source>J Cutan Pathol</source>
      <year>2009</year>
      <volume>36</volume>
      <fpage>1185</fpage>
      <lpage>1190</lpage>
    </element-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Remstein</surname>
          <given-names>ED</given-names>
        </name>
        <name>
          <surname>Arndt</surname>
          <given-names>CA</given-names>
        </name>
        <name>
          <surname>Nascimento</surname>
          <given-names>AG</given-names>
        </name>
      </person-group>
      <article-title>Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases</article-title>
      <source>Am J Surg Pathol</source>
      <year>1999</year>
      <volume>23</volume>
      <fpage>662</fpage>
      <lpage>670</lpage>
    </element-citation>
  </ref>

</ref-list>

</back>

<floats-group>

<fig position="float" id="F1">
<label>Fig. 1</label>
<caption>
  <title>A: T1-weighted, post-contrast, sagittal magnetic resonance imaging demonstrates a well-defined, heterogeneous, enhancing mass in the left parietal convexity with a focal cortical defect of the left parietal bone. B: A hard, whitish-grey mass with little bleeding was completely removed under general anesthesia.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btrt-4-17-g001"></graphic>
</fig>

<fig position="float" id="F2">
<label>Fig. 2</label>
<caption>
  <title>Histopathologic examination revealed a non-encapsulated tumor (A: H&#x0026;E, &#x00D7;40) composed of nests and bundles of epithelioid to spindle cells with sparse myxoid matrix (B: H&#x0026;E, &#x00D7;100), arranged in fascicles or nodules, often in a geographic pattern, separated by a collagen-rich stroma (C: H&#x0026;E, &#x00D7;100). Mild to moderate pleomorphism of epithelioid cells with indistinct border including a giant cell and a mitotic figure is observed (D: H&#x0026;E, &#x00D7;200). H&#x0026;E, hematoxylin and eosin.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btrt-4-17-g002"></graphic>
</fig>

<fig position="float" id="F3">
<label>Fig. 3</label>
<caption>
  <title>Immunohistochemical studies were focally positive for vimentin, neuron-specific enolase (A: &#x00D7;200), smooth muscle actin (B: &#x00D7;200), CD68 (C: &#x00D7;200), CD10 (D: &#x00D7;200) but negative for S-100 protein, HMB-45, epithelial membrane antigen, and CD34.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btrt-4-17-g003"></graphic>
</fig>

</floats-group>

</article>